TAIPEI (Taiwan News) — A Chinese biopharmaceutical company is in the process of acquiring the license for a Canadian mRNA COVID-19 vaccine, including the rights to the Taiwan market and other countries in the region, raising the possibility of future complications…

Click here to view the original article.